ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Why Omnicell (OMCL) Stock Is Trading Up Today

OMCL Cover Image

What Happened?

Shares of healthcare tech company Omnicell (NASDAQ: OMCL) jumped 10.9% in the morning session after the company reported strong third-quarter 2025 financial results that beat expectations and raised its full-year guidance. The healthcare technology company announced revenue of $310.6 million, a 10% increase year on year and above analyst projections. Earnings also came in well ahead of forecasts, with a reported non-GAAP profit of $0.51 per share, significantly higher than the consensus estimate of $0.36 per share. In addition to the strong quarterly performance, Omnicell provided a positive outlook by raising its financial forecast for the full year and issuing guidance for the next quarter that was also above market expectations.

Is now the time to buy Omnicell? Access our full analysis report here.

What Is The Market Telling Us

Omnicell’s shares are quite volatile and have had 15 moves greater than 5% over the last year. But moves this big are rare even for Omnicell and indicate this news significantly impacted the market’s perception of the business.

The previous big move we wrote about was 20 days ago when the stock dropped 3.8% on the news that worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling a meeting with President Xi caused a rapid sell-off in the market. The trade dispute flared up after China imposed export controls on rare earth minerals, which are critical components for high-tech manufacturing. The escalation of the trade war raises concerns about supply chain disruptions and increased costs for technology companies, which are heavily reliant on global trade, leading to a broad sell-off in the sector.

Omnicell is down 23.9% since the beginning of the year, and at $33.72 per share, it is trading 36.4% below its 52-week high of $53.05 from October 2024. Investors who bought $1,000 worth of Omnicell’s shares 5 years ago would now be looking at an investment worth $389.64.

Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free for active Edge members and will only take you a second.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  243.04
-7.16 (-2.86%)
AAPL  269.77
-0.37 (-0.14%)
AMD  237.60
-18.73 (-7.31%)
BAC  53.29
+0.84 (1.60%)
GOOG  285.39
+0.64 (0.22%)
META  618.94
-17.01 (-2.67%)
MSFT  497.10
-10.06 (-1.98%)
NVDA  188.08
-7.13 (-3.65%)
ORCL  243.80
-6.51 (-2.60%)
TSLA  445.91
-16.16 (-3.50%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.